{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:50:36Z","timestamp":1792929036842,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","award":["EUPAS107615"],"award-info":[{"award-number":["EUPAS107615"]}],"id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jinf.2026.106825","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:37:23Z","timestamp":1785911843000},"page":"106825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths"],"prefix":"10.1016","volume":"93","author":[{"given":"Xintong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7948-3747","authenticated-orcid":false,"given":"N\u00faria","family":"Mercad\u00e9-Besora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-2328","authenticated-orcid":false,"given":"Amy Shuk-Man","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-3403","authenticated-orcid":false,"given":"Antonella","family":"Delmestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8274-0357","authenticated-orcid":false,"given":"Talita","family":"Duarte-Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Yi","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-8565","authenticated-orcid":false,"given":"Mees","family":"Mosseveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-9290","authenticated-orcid":false,"given":"Anna","family":"Palomar-Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-2970","authenticated-orcid":false,"given":"Berta","family":"Ravent\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-4904","authenticated-orcid":false,"given":"Katia","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00ed","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-0110","authenticated-orcid":false,"given":"Annika M.","family":"J\u00f6dicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jinf.2026.106825_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-2600(22)00101-1","article-title":"Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control study","volume":"10","author":"Tartof","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"14","key":"10.1016\/j.jinf.2026.106825_bib2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.vaccine.2023.02.020","article-title":"Assessing COVID-19 vaccine effectiveness against Omicron subvariants: report from a meeting of the World Health Organization","volume":"41","author":"Feikin","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2026.106825_bib3","unstructured":"European Medicines Agency (EMA). Comirnaty | European Medicines Agency (EMA). Updated 28\/11\/2024. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/comirnaty."},{"key":"10.1016\/j.jinf.2026.106825_bib4","unstructured":"European Medicines Agency (EMA). Spikevax (previously COVID-19 Vaccine Moderna) | European Medicines Agency (EMA). Updated 18\/09\/2024. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax."},{"issue":"10","key":"10.1016\/j.jinf.2026.106825_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad475","article-title":"Bivalent vaccine effectiveness among adults aged \u226565 years during the BA.5-Predominant period in Japan: the VENUS study","volume":"10","author":"Mimura","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"42","key":"10.1016\/j.jinf.2026.106825_bib6","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1016\/j.vaccine.2023.08.085","article-title":"COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron","volume":"41","author":"Meeraus","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jinf.2026.106825_bib7","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S1473-3099(23)00373-0","article-title":"Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study","volume":"23","author":"Tan","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2026.106825_bib8","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jamaoncol.2023.2271","article-title":"COVID-19 severity and waning immunity after up to 4 mRNA vaccine doses in 73\u00a0608 patients with cancer and 621\u00a0475 matched controls in Singapore: a nationwide cohort study","volume":"9","author":"Tan","year":"2023","journal-title":"JAMA Oncol"},{"issue":"29","key":"10.1016\/j.jinf.2026.106825_bib9","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1016\/j.vaccine.2023.06.016","article-title":"Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: interim results from an observational cohort study","volume":"41","author":"Ku","year":"2023","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.jinf.2026.106825_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/cid\/ciad345","volume":"77","author":"Wee","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2026.106825_bib11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3201\/eid2811.220918","article-title":"Effectiveness of second mRNA COVID-19 booster vaccine in immunocompromised persons and long-term care facility residents","volume":"28","author":"Kim","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2026.106825_bib12","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7129e1","article-title":"Effectiveness of 2, 3, and 4 COVID-19 mRNA vaccine doses among immunocompetent adults during periods when SARS-CoV-2 Omicron BA.1 and BA.2\/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022","volume":"71","author":"Link-Gelles","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.jinf.2026.106825_bib13","doi-asserted-by":"crossref","first-page":"dyaf077","DOI":"10.1093\/ije\/dyaf077","article-title":"Data resource profile update: CPRD GOLD","volume":"54","author":"Sanchez-Santos","year":"2025","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106825_bib14","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1093\/ije\/dyac026","article-title":"Data resource profile: the Integrated Primary Care Information (IPCI) database, The Netherlands","volume":"51","author":"de Ridder","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106825_bib15","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1093\/ije\/dyac068","article-title":"Data resource profile: the Information System for Research in Primary Care (SIDIAP)","volume":"51","author":"Recalde","year":"2022","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106825_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jamia\/ocad247","article-title":"OHDSI Standardized Vocabularies-a large-scale centralized reference ontology for international data harmonization","volume":"31","author":"Reich","year":"2024","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jinf.2026.106825_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2147\/CLEP.S419481","article-title":"Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research","volume":"15","author":"Ravent\u00f3s","year":"2023","journal-title":"Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.jinf.2026.106825_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"9596","key":"10.1016\/j.jinf.2026.106825_bib19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jinf.2026.106825_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/sim.5925","article-title":"Interpreting observational studies: why empirical calibration is needed to correct p-values","volume":"33","author":"Schuemie","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.jinf.2026.106825_bib21","unstructured":"JCVI statement on the COVID-19 booster vaccination programme for autumn 2022: update 3 September 2022 (2022)."},{"key":"10.1016\/j.jinf.2026.106825_bib22","unstructured":"European Centre for Disease Prevention and Control Overv Implement COVID-19 Vaccin Strateg Deploy plans EU\/EEA 2022.8 September 2022(https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Overview-vaccination-strategies-COVID-19-8-September-2022.pdf)."},{"issue":"17","key":"10.1016\/j.jinf.2026.106825_bib23","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.vaccine.2023.03.036","article-title":"Divergent COVID-19 vaccine policies: policy mapping of ten European countries","volume":"41","author":"Van Kessel","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2026.106825_bib24","unstructured":"More than 60% of people aged over 80 years have a second booster dose of COVID-19. 2022.11.11, 2022. https:\/\/www.lamoncloa.gob.es\/lang\/en\/gobierno\/news\/Paginas\/2022\/20221111_covid19-booster-dose.aspx."},{"key":"10.1016\/j.jinf.2026.106825_bib25","article-title":"Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged \u226550 years in Nordic countries: nationwide cohort study","volume":"382","author":"Andersson","year":"2023","journal-title":"Bmj"},{"issue":"6","key":"10.1016\/j.jinf.2026.106825_bib26","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/ije\/dyad114","article-title":"Effectiveness and durability of a second COVID-19 booster against severe outcomes among older people in Norway: a population-based cohort study comparing mono- and bivalent booster doses","volume":"52","author":"Stecher","year":"2023","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.jinf.2026.106825_bib27","article-title":"Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in \u226565\u2009years old population in six European countries, October 2021 to November 2022","volume":"17","author":"Kislaya","year":"2023","journal-title":"Influenza Other Respir Virus"},{"key":"10.1016\/j.jinf.2026.106825_bib28","unstructured":"European Centre for Disease Prevention and Control Interim Anal COVID-19 Vaccin Eff Hosp death Using Electron Health Rec Six Eur Ctries 2023."},{"issue":"15","key":"10.1016\/j.jinf.2026.106825_bib29","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1016\/j.vaccine.2024.04.049","article-title":"A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants","volume":"42","author":"Song","year":"2024","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.jinf.2026.106825_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076892","article-title":"Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis","volume":"13","author":"Rahman","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2026.106825_bib31","unstructured":"World Health Organisation. COVID-19 epidemiological update \u2013 6 November 2024. Updated 6\/11\/2024. https:\/\/www.who.int\/publications\/m\/item\/covid-19-epidemiological-update-edition-173."},{"issue":"6","key":"10.1016\/j.jinf.2026.106825_bib32","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41591-024-02939-2","article-title":"Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023","volume":"30","author":"Lazarus","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jinf.2026.106825_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1382849","article-title":"A scoping review of COVID-19 vaccine hesitancy: refusal rate, associated factors, and strategies to reduce","volume":"12","author":"Bahreini","year":"2024","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.jinf.2026.106825_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12070747","article-title":"Understanding COVID-19 Vaccine Hesitancy in the United States: A Systematic Review","volume":"12","author":"Nwachukwu","year":"2024","journal-title":"Vaccines"},{"issue":"26","key":"10.1016\/j.jinf.2026.106825_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126474","article-title":"Comparing COVID-19 booster vaccine acceptance in the United Kingdom, Germany, Austria, and Jordan: the role of protection motivation theory, conspiracy beliefs, social media use and religiosity","volume":"42","author":"Eberhardt","year":"2024","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jinf.2026.106825_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12070740","article-title":"Primary healthcare providers\u2019 views on periodic COVID-19 booster vaccination for themselves and their patients: a 2023 nationwide survey in Belgium","volume":"12","author":"Digregorio","year":"2024","journal-title":"Vaccines"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445326001519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:13:00Z","timestamp":1790601180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445326001519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0163445326001519"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106825","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106825"}}